# Axos Financial, Inc.: financial statements, quarterly

AX · NYSE · CIK 1299709 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ax.md) · [Financials](/companies/ax/financials.md) · [Filings](/companies/ax/filings.md) · [Insiders](/companies/ax/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ax/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [166](/filings/0001299709-25-000011.md) | [182](/filings/0001299709-25-000087.md) | [193 d](/filings/0001299709-26-000060.md) | [192](/filings/0001299709-25-000184.md) | [176](/filings/0001299709-26-000012.md) | [157](/filings/0001299709-26-000035.md) | [162 d](/filings/0001299709-26-000060.md) | [175](/filings/0001299709-26-000083.md) | [182](/filings/0001299709-26-000012.md) | [172](/filings/0001299709-26-000035.md) | [181 d](/filings/0001299709-26-000060.md) | [186](/filings/0001299709-26-000083.md) |
| Income tax | $m | [65.6](/filings/0001299709-25-000011.md) | [44.8](/filings/0001299709-25-000087.md) | [39.5 d](/filings/0001299709-26-000060.md) | [46.9](/filings/0001299709-25-000184.md) | [45.6](/filings/0001299709-26-000012.md) | [42.9](/filings/0001299709-26-000035.md) | [45.1 d](/filings/0001299709-26-000060.md) | [37.5](/filings/0001299709-26-000083.md) | [47.1](/filings/0001299709-26-000012.md) | [40.6](/filings/0001299709-26-000035.md) | [31.0 d](/filings/0001299709-26-000060.md) | [45.5](/filings/0001299709-26-000083.md) |
| Net income | $m | [152](/filings/0001299709-25-000011.md) | [111](/filings/0001299709-25-000087.md) | [105 d](/filings/0001299709-26-000060.md) | [112](/filings/0001299709-25-000184.md) | [105](/filings/0001299709-26-000012.md) | [105](/filings/0001299709-26-000035.md) | [111 d](/filings/0001299709-26-000060.md) | [112](/filings/0001299709-26-000083.md) | [128](/filings/0001299709-26-000012.md) | [125](/filings/0001299709-26-000035.md) | [125 d](/filings/0001299709-26-000060.md) | [130](/filings/0001299709-26-000083.md) |
| Diluted EPS | $ per share | [2.62](/filings/0001299709-25-000011.md) | [1.91](/filings/0001299709-25-000087.md) | not reported | [1.93](/filings/0001299709-25-000184.md) | [1.80](/filings/0001299709-26-000012.md) | [1.81](/filings/0001299709-26-000035.md) | not reported | [1.94](/filings/0001299709-26-000083.md) | [2.22](/filings/0001299709-26-000012.md) | [2.15](/filings/0001299709-26-000035.md) | not reported | [2.25](/filings/0001299709-26-000083.md) |
| Basic EPS | $ per share | [2.65](/filings/0001299709-25-000011.md) | [1.94](/filings/0001299709-25-000087.md) | not reported | [1.97](/filings/0001299709-25-000184.md) | [1.83](/filings/0001299709-26-000012.md) | [1.84](/filings/0001299709-26-000035.md) | not reported | [1.99](/filings/0001299709-26-000083.md) | [2.27](/filings/0001299709-26-000012.md) | [2.20](/filings/0001299709-26-000035.md) | not reported | [2.28](/filings/0001299709-26-000083.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.8](/filings/0001299709-24-000008.md) | [2.1](/filings/0001299709-24-000093.md) | [2.0](/filings/0001299709-25-000125.md) | [2.6](/filings/0001299709-24-000216.md) | [2.4](/filings/0001299709-25-000011.md) | [2.0](/filings/0001299709-25-000087.md) | [1.9](/filings/0001299709-26-000060.md) | [2.6](/filings/0001299709-25-000184.md) | [1.0](/filings/0001299709-26-000012.md) | [1.2](/filings/0001299709-26-000035.md) | [1.1](/filings/0001299709-26-000083.md) | [1.6](/filings/0001299709-26-000083.md) |
| Total assets | $bn | [21.6](/filings/0001299709-24-000008.md) | [22.6](/filings/0001299709-24-000093.md) | [22.9](/filings/0001299709-25-000125.md) | [23.6](/filings/0001299709-24-000216.md) | [23.7](/filings/0001299709-25-000011.md) | [24.0](/filings/0001299709-25-000087.md) | [24.8](/filings/0001299709-26-000060.md) | [27.4](/filings/0001299709-25-000184.md) | [28.2](/filings/0001299709-26-000012.md) | [29.2](/filings/0001299709-26-000035.md) | [30.0](/filings/0001299709-26-000083.md) | [30.8](/filings/0001299709-26-000083.md) |
| Total liabilities | $bn | [19.5](/filings/0001299709-24-000008.md) | [20.4](/filings/0001299709-24-000093.md) | [20.6](/filings/0001299709-25-000125.md) | [21.2](/filings/0001299709-24-000216.md) | [21.2](/filings/0001299709-25-000011.md) | [21.4](/filings/0001299709-25-000087.md) | [22.1](/filings/0001299709-26-000060.md) | [24.6](/filings/0001299709-25-000184.md) | [25.3](/filings/0001299709-26-000012.md) | [26.2](/filings/0001299709-26-000035.md) | [26.8](/filings/0001299709-26-000083.md) | [27.6](/filings/0001299709-26-000083.md) |
| Long-term debt | $bn | [0.3](/filings/0001299709-24-000008.md) | [0.3](/filings/0001299709-24-000093.md) | [0.3](/filings/0001299709-25-000125.md) | [0.3](/filings/0001299709-24-000216.md) | [0.4](/filings/0001299709-25-000011.md) | [0.4](/filings/0001299709-25-000087.md) | [0.3](/filings/0001299709-26-000060.md) | not reported | not reported | not reported | [0.3](/filings/0001299709-26-000060.md) | not reported |
| Shareholders' equity | $bn | [2.1](/filings/0001299709-25-000087.md) | [2.2](/filings/0001299709-25-000087.md) | [2.3](/filings/0001299709-26-000060.md) | [2.4](/filings/0001299709-26-000012.md) | [2.5](/filings/0001299709-26-000035.md) | [2.6](/filings/0001299709-26-000035.md) | [2.7](/filings/0001299709-26-000083.md) | [2.8](/filings/0001299709-26-000083.md) | [2.9](/filings/0001299709-26-000035.md) | [3.1](/filings/0001299709-26-000035.md) | [3.2](/filings/0001299709-26-000083.md) | [3.3](/filings/0001299709-26-000083.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [119 d](/filings/0001299709-25-000011.md) | [116 d](/filings/0001299709-25-000087.md) | [37.0 d](/filings/0001299709-26-000060.md) | [70.8](/filings/0001299709-25-000184.md) | [163 d](/filings/0001299709-26-000012.md) | [73.7 d](/filings/0001299709-26-000035.md) | [183 d](/filings/0001299709-26-000060.md) | [118](/filings/0001299709-26-000083.md) | [104 d](/filings/0001299709-26-000012.md) | [42.0 d](/filings/0001299709-26-000035.md) | [293 d](/filings/0001299709-26-000060.md) | [295](/filings/0001299709-26-000083.md) |
| Capital expenditure | $m | [10.5 d](/filings/0001299709-25-000011.md) | [8.4 d](/filings/0001299709-25-000087.md) | [10.5 d](/filings/0001299709-26-000060.md) | [17.8](/filings/0001299709-25-000184.md) | [6.1 d](/filings/0001299709-26-000012.md) | [8.6 d](/filings/0001299709-26-000035.md) | [21.8 d](/filings/0001299709-26-000060.md) | [9.1](/filings/0001299709-26-000083.md) | [18.7 d](/filings/0001299709-26-000012.md) | [143 d](/filings/0001299709-26-000035.md) | [95.3 d](/filings/0001299709-26-000060.md) | [59.4](/filings/0001299709-26-000083.md) |
| Share repurchases | $m | [64.1 d](/filings/0001299709-25-000011.md) | [0.6 d](/filings/0001299709-25-000087.md) | [13.1 d](/filings/0001299709-26-000060.md) | [0.0](/filings/0001299709-24-000216.md) | [0.0 d](/filings/0001299709-25-000011.md) | [25.9 d](/filings/0001299709-26-000035.md) | [32.3 d](/filings/0001299709-26-000060.md) | [0.0](/filings/0001299709-26-000083.md) | not reported | not reported | [22.0 d](/filings/0001299709-26-000060.md) | [4.0](/filings/0001299709-26-000083.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [60.0](/filings/0001299709-24-000008.md) | [59.9](/filings/0001299709-24-000093.md) | [58.9](/filings/0001299709-24-000216.md) | [57.2](/filings/0001299709-25-000011.md) | [56.9](/filings/0001299709-25-000087.md) | [56.9](/filings/0001299709-25-000184.md) | [57.1](/filings/0001299709-26-000012.md) | [57.0](/filings/0001299709-26-000035.md) | [56.5](/filings/0001299709-26-000083.md) | [56.7](/filings/0001299709-26-000012.md) | [56.7](/filings/0001299709-26-000035.md) | [56.8](/filings/0001299709-26-000083.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 56,721,014 at 2026-10-16, from the cover of the [10-Q filed 2026-10-29](/filings/0001299709-26-000083.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:50 ET. No prices; not investment advice.